novo nordisk weight loss

Novo Nordisk Says US Approves 1st GLP-1 Pill For Weight Loss

FDA approves Wegovy pill for weight loss: What to know

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk announced the approval of its oral Wegovy pill, an oral semaglutide medication, in a news release Monday.

· 3d · on MSN

How Novo Nordisk is trying to regain its weight-loss edge

· 3d

What Novo Nordisk's weight-loss pill approval means for company, patients

7don MSN

Eli Lilly, Novo Nordisk file competing new weight-loss drugs with the FDA that could be game changers in obesity medicine

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

22hon MSN

Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Novo Nordisk Says US Approves 1st GLP-1 Pill For Weight Loss

Eli Lilly, Novo Nordisk file competing new weight-loss drugs with the FDA that could be game changers in obesity medicine

Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle?

Trending now